Lanreotide Subcutaneous and Phenylephrine and triprolidine
Determining the interaction of Lanreotide Subcutaneous and Phenylephrine and triprolidine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: phenylephrine / triprolidine
Brand name: Prohist LQ, Histex PE, Histex-PE
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-Phenylephrine Complex
- Lanreotide Subcutaneous-Phenylephrine Eye Drops 10%
- Lanreotide Subcutaneous-Phenylephrine Eye Drops 2.5%
- Lanreotide Subcutaneous-Phenylephrine Hydrochloride
- Lanreotide Subcutaneous-Phenylephrine Hydrochloride Injection
- Lanreotide Subcutaneous-Phenylephrine Injection
- Phenylephrine and triprolidine-Lansoprazole
- Phenylephrine and triprolidine-Lansoprazole Delayed-Release Capsules
- Phenylephrine and triprolidine-Lansoprazole Orally Disintegrating Tablets
- Phenylephrine and triprolidine-Lansoprazole, Amoxicillin, and Clarithromycin
- Phenylephrine and triprolidine-Lanthanum
- Phenylephrine and triprolidine-Lanthanum carbonate